The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000646347
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
10/04/2026
Date registered
Help: Date registered
28/05/2026
Date last updated
Help: Date last updated
1/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
28/05/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
A clinical trial of a telehealth work support program for stroke survivors
Scientific title
A multisite, single-blind, parallel-group randomised controlled trial of a telehealth work support program versus usual care for adults with stroke
Additional trial identifiers [1] 316826 0
GNT2032498
Universal Trial Number (UTN)
U1111-1335-6224
Trial acronym
The RESET Trial
Related trial records

Health condition
Health condition(s) studied:
Stroke (haemorrhagic) 341304 0
Stroke (ischaemic) 341716 0
Stroke (not known if haemorrhagic or ischaemic) 341717 0
Condition category
Condition code
Stroke 337376 337376 0 0
Haemorrhagic
Stroke 337377 337377 0 0
Ischaemic

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Arm 1: Work Support Program (WSP)
The Work Support Program is a telehealth-delivered, individualised work support intervention for adults who have had a stroke. The program is delivered individually by trained Work Support Program Clinicians (health professionals) via telephone or videoconference. The WSP is guided by a facilitator manual based on pilot work and designed specifically for this trial. The program has four mandated sessions (assessment sessions and discharge), with the remaining sessions guided by the participants individual goals and needs.

The intervention includes:
• Having a WSP Clinician for up 6-months.
• Three specialised assessment sessions (up to 1 hour each or split across shorter sessions if required) that enable identification of gaps in care, barriers and facilitators to work, and an individualised Workplace Action Plan.
• This WSP Clinician will identify gaps in current supports/care; identify and facilitate referrals; and communicate with care providers/workplaces/support people as appropriate (and with permission) to ensure the participant is accessing appropriate supports/services.
• For those returning to work, the WSP Clinician will participate in development of a Return to Work Plan, and delivery of that plan, including liaison with workplaces (with permission).
• For those who are unemployed, the WSP Clinician will support liaison with disability employment services and assist in identifying and applying for potential jobs. Additional strategies (CV review; interview practice; role plays and so on) will be implemented as required.
• For those currently working, the WSP Clinician will support the participant in following their Workplace Action Plan, with revisions to the plan as new barriers emerge. This may include liaison with the workplace as required (with permission).
• Additional support around enhancing work-life balance will be provided as appropriate (psychoeducation, identification of barriers and strategy identification/goal setting). WSP clinicians will also be trained in supporting emotional adjustment to stroke, person centred goal setting and problem solving.
• A discharge plan at the end of the intervention delivery.

Training: WSP Clinicians will undergo structured training prior to delivery, including a minimum of 4 hours of online videos/reading; 3 hours of face to face training, and 3 hours of role plays prior to the first participant enrolment; followed by regular individual/group supervision and fidelity checks during study delivery.

Duration & Frequency: Up to 6 months post-enrolment. Frequency of sessions and number of sessions are not pre-specified, but will be agreed upon by the WSP Clinician and participant, based on their needs and goals. Session length will also vary depending on session content (approx. 15 minutes to 1 hour maximum). There are four mandated sessions, as such “per protocol” will be defined as a minimum of 4 sessions attended.

Mode: Telehealth (telephone or videoconference), delivered individually.

Delivered by: Trained Work Support Program clinicians (registered health professionals with at least 2 years clinical experience).

Fidelity: Clinical notes will be coded and audited. For fidelity analysis, Work Support Program Clinicians will digitally record the sessions (with client’s permission). On an ongoing basis an independent fidelity assessor will review audio recordings for 10% of randomly selected participants, rating against a checklist of expected activities according to the manual for percentage adherence, with any barriers to delivery and new/additional strategies not currently in the manual noted.

Intervention code [1] 333596 0
Rehabilitation
Intervention code [2] 333908 0
Treatment: Other
Description of the comparator or control
Treatment as usual (usual care): All participants (both arms) will be given a list of potentially relevant services that they can follow-up with themselves. Participants in the control group (usual care) will receive no further intervention from the study. There is no standardised RTW support in Australia; usual care will vary by location, health services and health providers and may be minimal (e.g. GP management of stroke), or may involve rehabilitation or other services with or without RTW expertise. Usual care will be documented.
Control group
Active

Outcomes
Primary outcome [1] 344894 0
Between-group (intervention vs usual care) differential change in work ability from baseline to 6 months measured by the Work Ability Index (WAI)
Timepoint [1] 344894 0
Baseline and 6 months post randomisation
Secondary outcome [1] 459656 0
Between-group (intervention vs usual care) differential change in work ability
Timepoint [1] 459656 0
Baseline, 3, 6 (primary outcome) and 12 months post- randomisation
Secondary outcome [2] 459657 0
Between-group (intervention vs usual care) differential change in productivity measured by the Work Productivity and Activity Impairment Questionnaire (WPAI)
Timepoint [2] 459657 0
Baseline, 3, 6 and 12-months post- randomisation
Secondary outcome [3] 459659 0
Between-group (intervention vs usual care) differences in work status (employed/not employed)
Timepoint [3] 459659 0
Baseline, 3, 6 and 12-months post- randomisation
Secondary outcome [4] 459678 0
Between-group (intervention vs usual care) differences in hours of work per week
Timepoint [4] 459678 0
Baseline, 3, 6 and 12-months post- randomisation
Secondary outcome [5] 459680 0
Between-group (intervention vs usual care) differential change in quality of life
Timepoint [5] 459680 0
Baseline, 6 and 12-months post- randomisation
Secondary outcome [6] 459682 0
Between-group (intervention vs usual care) differential change in depression
Timepoint [6] 459682 0
Baseline, 6 and 12-months post- randomisation
Secondary outcome [7] 459684 0
Between-group (intervention vs usual care) differential change in anxiety
Timepoint [7] 459684 0
Baseline, 6 (secondary outcome) and 12-months post- randomisation
Secondary outcome [8] 459687 0
Cost effectiveness measures: Intervention value for health service implementation
Timepoint [8] 459687 0
Baseline, 6 and 12 months post- randomisation
Secondary outcome [9] 467192 0
Fatigue (exploratory outcome; to be used in additional analyses exploring e.g. mediator/moderators and so on)
Timepoint [9] 467192 0
Baseline, 6 months and 12 months post-randomisation
Secondary outcome [10] 467193 0
Cognition (exploratory outcome; to be used in additional analyses exploring e.g. mediator/moderators and so on)
Timepoint [10] 467193 0
Baseline, 6- and 12-months post randomisation
Secondary outcome [11] 467194 0
Acceptability and satisfaction (process evaluation measure) - comparison between intervention and control group.
Timepoint [11] 467194 0
6-months post randomisation

Eligibility
Key inclusion criteria
(1) Aged 18+
(2) Residing in Australia
(3) Diagnosed with stroke (including ICD-11 diagnoses (or equivalent, depending on local coding systems) of Intracerebral haemorrhage, Subarachnoid haemorrhage, Cerebral ischemic stroke, or Stroke not known if ischaemic or haemorrhagic) at any time, confirmed by imaging
(4) Meet criteria of employment before stroke (work for average of =7 hours/week, including planned or sick leave, during the month prior to the stroke for pay/profit/commission/in-kind or in a family business)
(5) Have access to a phone
(6) Willing to provide contact details for their treating physician
(7) Willing to provide contact details for follow-up
(8) Can provide informed consent
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
(1) Not currently interested in engaging with or able to participate in a telehealth program targeting work ability and delivered in English, or not currently eligible to work in Australia
(2) Have been working at the same job for 60 days or more (post-stroke) and currently have good work ability (Work Ability Index score >=37)
(3) Currently enrolled in a compensable RTW program (e.g. WorkCover) or enrolled in a clinical trial judged not to be scientifically or medically compatible with this study

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is concealed. Randomisation is embedded within REDCap (central computerised randomisation). The allocation sequence was generated and is maintained by an independent statistician. Research staff informing participants of randomisation allocation only access randomisation results after baseline assessments are confirmed complete.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Permuted block randomisation with 1:1 allocation ratio, stratified by site and baseline employment status. The allocation sequence was generated by an independent statistician and is maintained within the REDCap database.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC
Recruitment hospital [1] 29344 0
John Hunter Hospital - New Lambton
Recruitment hospital [2] 29345 0
Barwon Health - Geelong Hospital campus - Geelong
Recruitment hospital [3] 29346 0
Flinders Medical Centre - Bedford Park
Recruitment postcode(s) [1] 45662 0
2305 - New Lambton
Recruitment postcode(s) [2] 45663 0
3220 - Geelong
Recruitment postcode(s) [3] 45664 0
5042 - Bedford Park

Funding & Sponsors
Funding source category [1] 321419 0
Government body
Name [1] 321419 0
National Health and Medical Research Council
Country [1] 321419 0
Australia
Funding source category [2] 321493 0
Other Collaborative groups
Name [2] 321493 0
Western Alliance
Country [2] 321493 0
Australia
Primary sponsor type
University
Name
Deakin University
Address
Country
Australia
Secondary sponsor category [1] 324249 0
None
Name [1] 324249 0
Address [1] 324249 0
Country [1] 324249 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319958 0
Hunter New England Human Research Ethics Committee
Ethics committee address [1] 319958 0
Ethics committee country [1] 319958 0
Australia
Date submitted for ethics approval [1] 319958 0
29/08/2025
Approval date [1] 319958 0
19/09/2025
Ethics approval number [1] 319958 0
2025/ETH00446

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 148962 0
A/Prof Alyna Turner
Address 148962 0
Health Education and Research Building (HERB) Level 3, Barwon Health, P.O. Box 281 Geelong VIC 3220 AUSTRALIA 
Country 148962 0
Australia
Phone 148962 0
+61 02 4215 3313
Fax 148962 0
Email 148962 0
Contact person for public queries
Name 148963 0
Alyna Turner
Address 148963 0
Health Education and Research Building (HERB) Level 3, Barwon Health, P.O. Box 281 Geelong VIC 3220 AUSTRALIA 
Country 148963 0
Australia
Phone 148963 0
+61 02 4215 3313
Fax 148963 0
Email 148963 0
Contact person for scientific queries
Name 148964 0
Alyna Turner
Address 148964 0
Health Education and Research Building (HERB) Level 3, Barwon Health, P.O. Box 281 Geelong VIC 3220 AUSTRALIA 
Country 148964 0
Australia
Phone 148964 0
+61 02 4215 3313
Fax 148964 0
Email 148964 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• Selected de-identified individual participant data from consenting participants; not including data from Service Australia (PBS/MBS data).

What types of analyses could be done with individual participant data?
• To achieve aims in an approved proposal.

When can requests for individual participant data be made (start and end dates)?
From:
12 months following main results publication

To:
Not yet decided
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.